Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
Published June 21, 2017 · Recall initiated: May 18, 2017
Summary
FDA records drug Class II recall D-0898-2017, published June 21, 2017 and initiated May 18, 2017. Recalling firm: Hospira Inc., A Pfizer Company; Status: Terminated; Reported quantity: (720503A): 43,200 vials, (720603A): 400 vials; Lot: 720503A, 720603A (Canada only). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOPHED has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOPHED
- Manufacturer
- Hospira Inc., A Pfizer Company
- Distributor
- Nationwide, Canada and Singapore
- Lot
- 720503A, 720603A (Canada only)
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose FliptopSeptember 27, 2017
- FDANasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) meteredJune 21, 2017
- FDAAcetaminophen 325mg tablets, 120-count bottles, Pk By Safecor Health Woburn, MA 01801, NDC 00904198280.June 21, 2017
- FDAResponse BandLoc 5.5/6.0 Tensioner Instrument The Tensioner Instrument (01-1102-1000) is utilized to allow theJune 14, 2017
- FDANBS System 4 (sw version 4.0 or higher), Software update to 4.3.3 and NBS System 5 (sw version 5.0 or higher),June 14, 2017
- FDANexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBSJune 14, 2017
Questions about this recall
Was Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04 recalled?
Yes. FDA published recall D-0898-2017 on June 21, 2017. Reported hazard: GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOPHED.